Targeting the IL-17–TH17 pathway
Targeting the IL-17–TH17 pathway
About this item
Full title
Targeting the IL-17–TH17 pathway
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Nature reviews. Drug discovery, 2015-01, Vol.14 (1), p.11-12
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
The IL-17–T
H
17 pathway is a popular target for the treatment of psoriasis and other autoimmune conditions. Bartlett and Million discuss the key agents in the pipeline, several of which are expected to gain approval in the near future.
Alternative Titles
Full title
Targeting the IL-17–TH17 pathway
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_1658764276
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1658764276
Other Identifiers
ISSN
1474-1776
E-ISSN
1474-1784
DOI
10.1038/nrd4518
How to access this item
Log in as a Library member
